Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:14:33 EDT Wed 08 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:BEAM from 2023-05-09 to 2024-05-08 - 20 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2024-05-07 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
2024-03-26 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
2024-02-28 06:30
U
U:BEAM
News Release
200
Beam Therapeutics to Participate in Upcoming March 2024 Investor Conferences
2024-02-27 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones
2024-02-05 06:30
U
U:BEAM
News Release
200
Beam Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
2024-01-08 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Highlights Progress Across Base Editing Portfolio and Outlines 2024 Anticipated Milestones
2024-01-02 06:30
U
U:BEAM
News Release
200
Beam Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-14 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
2023-11-08 06:30
U
U:BEAM
News Release
200
Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference
2023-11-08 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
2023-10-31 06:00
U
U:BEAM
News Release
200
Beam Announces Agreement for Lilly to Acquire Beam ¢ € ™s Opt-In Rights to Verve Therapeutics ¢ € ™ Base Editing Programs for Cardiovascular Disease
2023-10-25 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Presents Preclinical Data Highlighting Utility and Durability of BEAM-301 to Correct a Glycogen Storage Disease Type I Deficiency Disease-Causing Mutation at ESGCT
2023-10-19 08:45
U
U:BEAM
News Release
200
Beam Therapeutics Announces Portfolio Prioritization and Strategic Restructuring Focused on Potential Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines Pipeline
2023-09-07 10:00
U
U:BEAM
News Release
200
Beam Therapeutics Presents Preclinical Data Highlighting Utility of ‚ BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation
2023-09-05 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
2023-08-31 06:30
U
U:BEAM
News Release
200
Beam Therapeutics to Participate in Upcoming September Investor Conferences
2023-08-08 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
2023-05-17 06:30
U
U:BEAM
News Release
200
Beam Therapeutics to Participate in Upcoming May Investor Conferences
2023-05-11 06:30
U
U:BEAM
News Release
200
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference
2023-05-10 06:30
U
U:BEAM
News Release
200
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results